收费全文 | 652篇 |
免费 | 73篇 |
耳鼻咽喉 | 2篇 |
儿科学 | 14篇 |
妇产科学 | 7篇 |
基础医学 | 120篇 |
口腔科学 | 8篇 |
临床医学 | 124篇 |
内科学 | 188篇 |
皮肤病学 | 2篇 |
神经病学 | 43篇 |
特种医学 | 14篇 |
外科学 | 33篇 |
综合类 | 8篇 |
一般理论 | 1篇 |
预防医学 | 56篇 |
眼科学 | 7篇 |
药学 | 36篇 |
肿瘤学 | 62篇 |
2023年 | 8篇 |
2022年 | 2篇 |
2021年 | 10篇 |
2020年 | 24篇 |
2019年 | 20篇 |
2018年 | 16篇 |
2017年 | 13篇 |
2016年 | 21篇 |
2015年 | 21篇 |
2014年 | 27篇 |
2013年 | 34篇 |
2012年 | 41篇 |
2011年 | 52篇 |
2010年 | 36篇 |
2009年 | 44篇 |
2008年 | 44篇 |
2007年 | 35篇 |
2006年 | 45篇 |
2005年 | 44篇 |
2004年 | 36篇 |
2003年 | 28篇 |
2002年 | 16篇 |
2001年 | 11篇 |
2000年 | 15篇 |
1999年 | 6篇 |
1998年 | 4篇 |
1997年 | 4篇 |
1996年 | 7篇 |
1995年 | 7篇 |
1994年 | 6篇 |
1993年 | 5篇 |
1992年 | 3篇 |
1991年 | 6篇 |
1990年 | 3篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1982年 | 3篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1976年 | 4篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1970年 | 1篇 |
The design consisted of a multicenter blinded randomized trial. The control group received 10 mg of ascorbic acid twice daily.
Patients from 11 nursing homes and 1 hospital participated.
Main outcome measures included wound survival, healing rates of wound surfaces, and clinimetric changes over 12 weeks.
Eighty-eight patients were randomized. Intention-to-treat analysis showed that the wound closure probability per unit time (i.e., the closure rate) was not higher in the intervention group than in the control group (Cox hazard ratio of 0.78 [90% precision interval, 0.44–1.39]). Mean absolute healing rates were 0.21 and 0.27 cm2/week in the intervention and control group, respectively (PI of the adjusted difference: −0.17 to 0.13). Relative healing rates and healing velocities did not show favorable results of ascorbic acid supplementation, either. A panel scored slides of the ulcers with a report mark between 1 (bad) and 10 (excellent). The improvement was 0.45 and 0.72 points per week in the intervention and control group, respectively (PI of the adjusted difference: −0.50 to 0.20). With another clinimetric index we could not show any differences, either.
These data do not support the idea that ascorbic acid supplementation (500 vs. 10 mg twice daily) speeds up the healing of pressure ulcers. 相似文献
Method: All patients of the epilepsy center Kempenhaeghe that received topiramate (TPM) or levetiracetam (LEV) from the introduction to mid 2004 were analyzed using a medical information system, an automated medical file. Patients were analyzed after 6, 12, and 18 months of treatment.
Results: Four hundred and two patients used either TPM (n = 260) or LEV (n = 142); 18 months retention showed a statistically significant difference, revealing 15% more patients that continued LEV compared to TPM: 18 months retention 46% for TPM and 61% for LEV [F (1.400) = 3.313, p = 0.043]. Neurocognitive complaints accounted for a significant number of drug discontinuations and especially the high frequency of neurocognitive complaints in the first period of TPM treatment appeared to be significant different from LEV [F(2,547) = 3.192, p = 0.042]. In the remaining patients, the difference in neurocognitive complaints was not statistically significant.
Conclusion: cognitive complaints are common in TPM treatment and frequently lead to drug withdrawal. The impact of LEV on cognitive function is only mild. This leads to a much higher (15%) drug discontinuation rate for TPM compared to LEV. 相似文献